Literature DB >> 30867721

miR-212 regulated by HIF-1α promotes the progression of pancreatic cancer.

Hui Yue1, Lin Liu1, Zhenguo Song1.   

Abstract

MicroRNA-212 (miR-212) is dysregulated in numerous tissues and cancer types and serves a role in the progression of human cancer. However, the function and mechanism of miR-212 in the development of pancreatic ductal adenocarcinoma (PDAC) remain unknown, particularly in a hypoxic microenvironment. In the present study, miR-212 expression was observed to be significantly upregulated in PDAC tissues compared with normal tissues. Clinical data analysis indicated that miR-212 was positively associated with a large tumor size, Tumor-Node-Metastasis stage, lymph node metastasis and vessel invasion, and influenced the overall survival time. Notably, there was a positive association between the expression of hypoxia-inducible factor-1α (HIF-1α) and miR-212 in vivo and in vitro in hypoxic conditions. Mechanistically, HIF-1α bound directly to a hypoxia response element in the miR-212 promoter region and activated miR-212 expression in PDAC cells. Collectively, these results demonstrated that HIF-1α positively regulated miR-212 expression and resulted in PDAC progression.

Entities:  

Keywords:  hypoxia-inducible factor-1α; microRNA-212; pancreatic cancer; progression

Year:  2019        PMID: 30867721      PMCID: PMC6396010          DOI: 10.3892/etm.2019.7213

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  12 in total

1.  MicroRNA-212-5p, an anti-proliferative miRNA, attenuates hypoxia and sugen/hypoxia-induced pulmonary hypertension in rodents.

Authors:  Tianji Chen; Miranda R Sun; Qiyuan Zhou; Alyssa M Guzman; Ramaswamy Ramchandran; Jiwang Chen; Dustin R Fraidenburg; Balaji Ganesh; Mark Maienschein-Cline; Karl Obrietan; J Usha Raj
Journal:  Mol Ther Nucleic Acids       Date:  2022-06-22       Impact factor: 10.183

Review 2.  Hypoxia signaling in human health and diseases: implications and prospects for therapeutics.

Authors:  Zhen Luo; Mingfu Tian; Ge Yang; Qiaoru Tan; Yubing Chen; Geng Li; Qiwei Zhang; Yongkui Li; Pin Wan; Jianguo Wu
Journal:  Signal Transduct Target Ther       Date:  2022-07-07

Review 3.  Pancreatic Cancer and Microenvironments: Implications of Anesthesia.

Authors:  Hou-Chuan Lai; Yi-Wei Kuo; Yi-Hsuan Huang; Shun-Ming Chan; Kuang-I Cheng; Zhi-Fu Wu
Journal:  Cancers (Basel)       Date:  2022-05-28       Impact factor: 6.575

4.  Prognostic value of microRNAs in pancreatic cancer: a meta-analysis.

Authors:  Fei Zhao; Chao Wei; Meng-Ying Cui; Qiang-Qiang Xia; Shuai-Bin Wang; Yue Zhang
Journal:  Aging (Albany NY)       Date:  2020-05-18       Impact factor: 5.682

Review 5.  Targeting hypoxic tumor microenvironment in pancreatic cancer.

Authors:  Jinxin Tao; Gang Yang; Wenchuan Zhou; Jiangdong Qiu; Guangyu Chen; Wenhao Luo; Fangyu Zhao; Lei You; Lianfang Zheng; Taiping Zhang; Yupei Zhao
Journal:  J Hematol Oncol       Date:  2021-01-13       Impact factor: 17.388

Review 6.  Systematic review and meta-analysis of the prognostic significance of microRNAs related to metastatic and EMT process among prostate cancer patients.

Authors:  Martyna Parol; Arkadiusz Gzil; Magdalena Bodnar; Dariusz Grzanka
Journal:  J Transl Med       Date:  2021-01-07       Impact factor: 5.531

Review 7.  Crosstalk of MicroRNAs and Oxidative Stress in the Pathogenesis of Cancer.

Authors:  Can Lu; Danting Zhou; Qiang Wang; Wenliang Liu; Fenglei Yu; Fang Wu; Chen Chen
Journal:  Oxid Med Cell Longev       Date:  2020-04-28       Impact factor: 6.543

8.  MicroRNA-519 inhibits hypoxia-induced tumorigenesis of pancreatic cancer by regulating immune checkpoint PD-L1.

Authors:  Kate Nong; Dong Zhang; Changze Chen; Yue Yang; Yong Yang; Shengyong Liu; Huihua Cai
Journal:  Oncol Lett       Date:  2019-12-20       Impact factor: 2.967

9.  Novel therapies targeting hypoxia mechanism to treat pancreatic cancer.

Authors:  Wenhao Luo; Jiangdong Qiu; Lianfang Zheng; Taiping Zhang
Journal:  Chin J Cancer Res       Date:  2021-04-30       Impact factor: 5.087

10.  The clinical significance of microRNA-409 in pancreatic carcinoma and associated tumor cellular functions.

Authors:  Kui Long; Qingbin Zeng; Wenzhi Dong
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.